Projects funded by the NCN
Identification of the mechanism of antineoplastic activity of metformin, as an experimental approach to improve cancer treatment.
2017/25/B/NZ7/02183
Keywords:
metformin PRODH POX proline AMPK apoptosis autophagy
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Medyczny w Białymstoku, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej
woj. podlaskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 7
Call: OPUS 13 - announced on 2017-03-15
Amount awarded: 1 852 060 PLN
Project start date (Y-m-d): 2018-05-07
Project end date (Y-m-d): 2022-05-06
Project duration:: 48 months (the same as in the proposal)
Project status: Project settled
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.